{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:04:05Z","timestamp":1785229445956,"version":"3.55.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","award":["R40-A2022-11-S2"],"award-info":[{"award-number":["R40-A2022-11-S2"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Danish Council for Independent Research: Medical Sciences","award":["DFF-4004-00362"],"award-info":[{"award-number":["DFF-4004-00362"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hyperthermia"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/02656736.2026.2692414","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:40:08Z","timestamp":1785228008000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["An exploratory pre-clinical study of the combination of hyperthermia and checkpoint inhibitors"],"prefix":"10.1080","volume":"43","author":[{"given":"Pernille B.","family":"Elming","sequence":"first","affiliation":[{"name":"Experimental Clinical Oncology, Aarhus University Hospital","place":["Aarhus, Denmark"]},{"name":"Department of Oncology, Aarhus University Hospital","place":["Aarhus, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Department of Clinical Medicine, Aarhus University Hospital","place":["Aarhus, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Alsner","sequence":"additional","affiliation":[{"name":"Experimental Clinical Oncology, Aarhus University Hospital","place":["Aarhus, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Horsman","sequence":"additional","affiliation":[{"name":"Experimental Clinical Oncology, Aarhus University Hospital","place":["Aarhus, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.208"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.012"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fonc.2014.00385","article-title":"CTLA-4 and PD-1 pathway blockade: combinations in the clinic","volume":"4","author":"Callahan MK","year":"2015","unstructured":"Callahan MK, Postow MA, Wolchok JP. CTLA-4 and PD-1 pathway blockade: combinations in the clinic. Front Oncol. 2015;4:385.","journal-title":"Front Oncol"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia SJ","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D, et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. NEJM. 2017;377:1919\u20131929.","journal-title":"NEJM"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4358"},{"key":"e_1_3_4_8_1","first-page":"e731\u2013741","article-title":"De\u2010novo and acquired resistance to immune Checkpoint targeting","volume":"18","author":"Syn NL","year":"2017","unstructured":"Syn NL, Teng MWL, Mok TSK, et al. De\u2010novo and acquired resistance to immune Checkpoint targeting. Lancet Oncol. 2017;18:e731\u2013741.","journal-title":"Lancet Oncol"},{"key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune\u2010mediated inhibition of metastases after treatment with local radiation and CTLA\u20104 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria S","year":"2005","unstructured":"Demaria S, Kawashima N, Yang AM, et al. Immune\u2010mediated inhibition of metastases after treatment with local radiation and CTLA\u20104 blockade in a mouse model of breast cancer. Clin Cancer Res. 2005;11:728\u2013734.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0265"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0210"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1258"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.05.007"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.11.001"},{"key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"20170157","DOI":"10.1259\/bjr.20170157","article-title":"Combining radiotherapy with immunotherapy: the past, the present and the future","volume":"90","author":"Van Lindberger EJ","year":"2017","unstructured":"Van Lindberger EJ, De Ruysscher DK, Olivo Pimentel V, et al. Combining radiotherapy with immunotherapy: the past, the present and the future. Br J Radiol. 2017;90:20170157.","journal-title":"Br J Radiol"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1080\/0284186X.2023.2238550","article-title":"Using immunotherapy to enhance the response of a C3H mammary carcinoma to proton radiation","volume":"62","author":"Nielsen Nielsen S","year":"2023","unstructured":"Nielsen Nielsen S, Sitarz MK, Sinha PM, et al. Using immunotherapy to enhance the response of a C3H mammary carcinoma to proton radiation. Acta Oncol. 2023;62:1581\u20131586.","journal-title":"Acta Oncol"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134778"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1628"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx7002195"},{"key":"e_1_3_4_20_1","first-page":"8","volume-title":"In: basic Clinical radiobiology","author":"Vens C","year":"2018","unstructured":"Vens C, Koritzinsky M, Wouters BG. Irradiation.induced damageand the DNA repair response. In: basic Clinical radiobiology. Joiner MC, van der Kogel J, Eds. CRC press\/Taylor & Francis Group, Boca Raton, FL, USA; 2018. pp. 8\u201320."},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1667\/RR15346.1"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2007.03.015"},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11010060","article-title":"Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia","volume":"11","author":"Elming PB","year":"2019","unstructured":"Elming PB, S\u00f8rensen BS, Oei AL, et al. Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia. Cancers (Basel). 2019;11:1\u201320.","journal-title":"Cancers (Basel)"},{"key":"e_1_3_4_24_1","first-page":"84","volume-title":"Adv Drug Deliv Rev","author":"Oei AL","year":"2020","unstructured":"Oei AL, Kok HP, Oei SB, et al. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Adv Drug Deliv Rev. 2020;163-164:84\u201397."},{"key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02656736.2012.677933","article-title":"International journal of hyperthermia old and new facts about hyperthermia\u2010induced modulations of the immune system old and new facts about hyperthermia\u2010induced modulations of the immune system","volume":"28","author":"Frey B","year":"2012","unstructured":"Frey B, Weiss E\u2010M, Rubner Y, et al. International journal of hyperthermia old and new facts about hyperthermia\u2010induced modulations of the immune system old and new facts about hyperthermia\u2010induced modulations of the immune system. Int J Hyperth. 2012;28:528\u2013542.","journal-title":"Int J Hyperth"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02656736.2014.968640","article-title":"Local tumour hyperthermia as immunotherapy for metastatic cancer Hyperthermia therapy for cancer treatment","volume":"30","author":"Toraya\u2010Brown S","year":"2014","unstructured":"Toraya\u2010Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer Hyperthermia therapy for cancer treatment. Int J Hyperth. 2014;30:531\u2013539.","journal-title":"Int J Hyperth"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2016.1157216"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2015.1106011"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(80)90008-5"},{"key":"e_1_3_4_30_1","first-page":"123","article-title":"Hydralazine\u2010induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo","volume":"5","author":"Horsman MR","year":"1989","unstructured":"Horsman MR, Christensen KL, Overgaard J. Hydralazine\u2010induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. Int J Hyperth. 1989;5:123\u2013136.","journal-title":"Int J Hyperth"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/02656738709140375"},{"key":"e_1_3_4_32_1","first-page":"7430","article-title":"Combination of nicotinamide and hyperthermia to eliminate chronically and acutely hypoxic tumour cells","volume":"50","author":"Horsman MR","year":"1990","unstructured":"Horsman MR, Chaplin DJ, Overgaard J. Combination of nicotinamide and hyperthermia to eliminate chronically and acutely hypoxic tumour cells. Cancer Res. 1990;50:7430\u20137436.","journal-title":"Cancer Res"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0118"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(83)80019-X"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3109\/02656738709140403"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2018.1492027"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2021.1875059"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001691"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(97)00220-X"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1982.300"}],"container-title":["International Journal of Hyperthermia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02656736.2026.2692414","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/02656736.2026.2692414","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02656736.2026.2692414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:40:11Z","timestamp":1785228011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02656736.2026.2692414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/02656736.2026.2692414"],"URL":"https:\/\/doi.org\/10.1080\/02656736.2026.2692414","relation":{},"ISSN":["0265-6736","1464-5157"],"issn-type":[{"value":"0265-6736","type":"print"},{"value":"1464-5157","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihyt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihyt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2692414"}}